Molecular cytogenetics as a tools for predicting cancer prognosis with special reference to neuroblastoma tumors
Folha méd
;
117(2): 135-40, set.-out. 1998. ilus, tab
Article
in English
| LILACS
| ID: lil-258171
ABSTRACT
Consistent cytogenetic abnormalities have been identified in a variety of human cancer cells and some of them are related to patiente prognosis. Fluorescence "in situ" hybridization (FISH) is a new methodology which can be used to detect cytogenetic anomalies within interphase cells. We present several aspects of FISH methodology and its application in several examples, including trisomy 8 detection with higt specificity and sensitivy in patients with myeloid leukemias; trisomy 12 detection with highter efficiency than conventional cytogenetics in patients with chronic lymphocytic leukemia; assessment of engraftment success; chimerism, and relapse in opposite sex bone marrow transplantation; and correlation of trisomy 7 with survival time in patients with prostate tumors. We discuss also some aspects of neuroblastoma tumors, one of the most frequent malignant solid tumor in childhood. At diagnosis the patient's age and tumor stage are the major prognostic factors. Favorable prognosis is associated with triploid karyotype, lack of 1 p abnormalities and absence of N-myc amplification, whereas unfavorable prognosis is associated with pseudodiploid or tetraploid karyotype, 1 p deletion and N-myc amplification. These abnormalities can be investigated quickly and effecctively in interphase cells using FISH.
Search on Google
Index:
LILACS (Americas)
Main subject:
Cytogenetic Analysis
/
Neoplasms
Type of study:
Diagnostic study
/
Prognostic study
/
Risk factors
Limits:
Child, preschool
/
Humans
/
Infant
Language:
English
Journal:
Folha méd
Journal subject:
Medicine
Year:
1998
Type:
Article
Similar
MEDLINE
...
LILACS
LIS